1.The Characteristics of Clinical Presentation and In-hospital Outcome of Acute Myocardial Infarction Patients Older than 65 Years of Age.
Jun Ho SEOK ; Jun Yeong KWUN ; Jae Lyun LEE ; Gue Ru HONG ; Dae Jin JEON ; Jong Sun PARK ; Dong Gu SHIN ; Yeong Jo KIM ; Bong Sup SHIM
Korean Circulation Journal 1997;27(4):386-393
BACKGROUND: The aging of the patient population is one of rhe most important factirs influencing health care delivery. Currently 5% of the Korean population is elderly, defined as older than 65years of age, with this group projected to increase to 13.1% by the year 2021. Cardiovascular disease is the leading cause of death and of disability in the elderly age group. mong them, coronary heart disease is the most importane. METHOD: Study population composed of 216 patients who were admittied to the hospital with first acute myocardial infarction and they were divided into two groups according to the age(older than 65 years of age vs younger). Clonical features, risk factors of coronary heart disease, in-hospital outcome and complication were compared in elderly patients and others group. Results : 1) The risk factors of coronary heart disease is similar to younger patients but pattern of chest pain is less typical than younger patients. 2) Clinical presentation of elderly patients is similar to younger patients except Killip class on admission.(1.66vs 1.91,P=0.04) 3) In-hospital mortality of elderly patients in higher than younger patients. In addition to an increased incidence of death, recurrent ischemia, stroke, AV block, ventricular arrythmia, pulmonary edema occured more frequently with advanced age. 4) Especially in the thrombolytic therapy group, in-hospital death, reinfarction and recurrent ischemia is higher than primary PTCA group in elderly patients. CONCLUSIONS: Diagnosis of acute chest pain is difficult in elderly patients and in-hospital mortality and morbidity is higher than in younger patients. Thus more accurate diagnosis and discriminative therapeutic modality is needed.
Aged
;
Aging
;
Arrhythmias, Cardiac
;
Atrioventricular Block
;
Cardiovascular Diseases
;
Cause of Death
;
Chest Pain
;
Coronary Disease
;
Delivery of Health Care
;
Diagnosis
;
Hospital Mortality
;
Humans
;
Incidence
;
Ischemia
;
Myocardial Infarction*
;
Pulmonary Edema
;
Risk Factors
;
Stroke
;
Thrombolytic Therapy
2.Deoxypodophyllotoxin Induces a Th1 Response and Enhances the Antitumor Efficacy of a Dendritic Cell-based Vaccine.
Jun Sik LEE ; Dae Hyun KIM ; Chang Min LEE ; Tae Kwun HA ; Kyung Tae NOH ; Jin Wook PARK ; Deok Rim HEO ; Kwang Hee SON ; In Duk JUNG ; Eun Kyung LEE ; Yong Kyoo SHIN ; Soon Cheol AHN ; Yeong Min PARK
Immune Network 2011;11(1):79-94
BACKGROUND: Dendritic cell (DC)-based vaccines are currently being evaluated as a novel strategy for tumor vaccination and immunotherapy. However, inducing long-term regression in established tumor-implanted mice is difficult. Here, we show that deoxypohophyllotoxin (DPT) induces maturation and activation of bone marrow-derived DCs via Toll-like receptor (TLR) 4 activation of MAPK and NF-kappaB. METHODS: The phenotypic and functional maturation of DPT-treated DCs was assessed by flow cytometric analysis and cytokine production, respectively. DPT-treated DCs was also used for mixed leukocyte reaction to evaluate T cell-priming capacity and for tumor regression against melanoma. RESULTS: DPT promoted the activation of CD8+ T cells and the Th1 immune response by inducing IL-12 production in DCs. In a B16F10 melanoma-implanted mouse model, we demonstrated that DPT-treated DCs (DPT-DCs) enhance immune priming and regression of an established tumor in vivo. Furthermore, migration of DPT-DCs to the draining lymph nodes was induced via CCR7 upregulation. Mice that received DPT-DCs displayed enhanced antitumor therapeutic efficacy, which was associated with increased IFN-gamma production and induction of cytotoxic T lymphocyte activity. CONCLUSION: These findings strongly suggest that the adjuvant effect of DPT in DC vaccination is associated with the polarization of T effector cells toward a Th1 phenotype and provides a potential therapeutic antitumor immunity.
Animals
;
Dendritic Cells
;
Immunotherapy
;
Interleukin-12
;
Lymph Nodes
;
Lymphocyte Culture Test, Mixed
;
Lymphocytes
;
Mice
;
Phenotype
;
Podophyllotoxin
;
T-Lymphocytes
;
Toll-Like Receptors
;
Up-Regulation
;
Vaccination
;
Vaccines
3.Buerger's Disease in Korea.
Jang Sang PARK ; Geun Eun KIM ; Seong Ki MIN ; Sun cheol PARK ; In Sung MOON ; Sung HEO ; Ho Chul PARK ; Won Hyun JO ; Hyung Tae KIM ; Do Kyun KIM ; Jong Kwon PARK ; Ki Hyuk PARK ; Jeong An LEE ; Joong Ki JUNG ; Sang Joon KIM ; Jong Won HA ; Young Wook KIM ; Dong Ik KIM ; Yong Sin KIM ; Seok Yul LEE ; Koing Bo KWUN ; Bo Yang SEO ; Tae Won KWON ; Hong Rae JO ; Byung Jun SO ; Hee Jae JUN ; Sang Yeong JUNG ; Oh Jeong KWON ; Hyun Chul KIM
Journal of the Korean Society for Vascular Surgery 2005;21(2):105-112
PURPOSE: Buerger's disease (Thromboangiitis obliterans, TAO) is characterized by non- atheromatous inflammatory disease, and segmental inflammatory thrombotic occlusions of the small & middle-sized arteries and veins of the upper or lower extremities. Any epidemiological study of Buerger's disease in Korea has not been carried out until now. This study was undertaken to investigate the incidence of Buerger's disease in Korea among the patients suffering with arterial disease. METHODS: We collected and analyzed the data on 11,128 patients who were admitted to or visited the participating 22 hospitals for chronic arterial diseases throughout the major region of the South Korea from January 1986 to December 2003. The clinical diagnostic inclusion criteria for Buerger's disease were the followings: (1) a history of smoking or tobacco abuse; (2) an age of onset less than 50 years; (3) infrapopliteal, segmental arterial occlusions with sparing of the proximal vasculature; (4) frequent distal upper extremity arterial involvement (Raynaud's syndrome or digital ulceration) or-superficial phlebitis; and (5) the absence of arteriosclerotic risk factors other than smoking. RESULTS: The incidence rate of Buerger's disease among the arterial disease (11,128 patients) was 93 patients (0.83%) when the strict criteria of Shionoya was applied. 699 male-patients (6.55%) and 30 female patients (4.12%) who met the less strict criteria (the extended clinical diagnostic criteria group) were also reviewed. The 4th and 5th decades were the most common ages with-249 patients (34.2%) and 222 patients (30.5%) respectively, being found at these ages. The mean age was 40.4+/-1.6 years (age range: 16~83 years) and this was similar in both the strict criteria group and the less strict criteria group. CONCLUSIONS: This study suggests there was a low incidence of Buerger's disease in Korea among the patients who visited the participating hospitals when the strict diagnostic criteria were used. The incidence was lower than expected even when the less strict criteria were used. The more accurate incidence of Buerger's disease among the general population can be obtained by performing careful prospective study that is participated in by not only vascular surgeons, but also the other medical specialists with utilizing the strict diagnostic criteria.
Age of Onset
;
Arteries
;
Epidemiologic Studies
;
Female
;
Humans
;
Incidence
;
Korea*
;
Lower Extremity
;
Phlebitis
;
Risk Factors
;
Smoke
;
Smoking
;
Specialization
;
Thromboangiitis Obliterans*
;
Tobacco
;
Upper Extremity
;
Veins